Fildena Professional, which contains sildenafil citrate, is primarily used for treating erectile dysfunction (ED). While sildenafil citrate (the active ingredient) was first introduced as a medication under the brand name Viagra in 1998, Fildena Professional itself is a generic version that has been available for a few years, primarily produced in India and marketed for ED treatment.

Academic research focusing on sildenafil citrate in various formulations, including generics like Fildena Professional, began shortly after the initial approval of Viagra. In the early 2000s, researchers started exploring the effectiveness, side effects, and broader applications of sildenafil. These studies were not limited to ED but also examined potential uses for other conditions, like pulmonary hypertension and cardiovascular issues.

However, research specifically involving Fildena Professional or its impact on ED treatment in a generic context began to gain more traction in academic circles in the 2010s. Researchers have focused on comparing generic sildenafil formulations like Fildena to branded versions for bioequivalence, efficacy, safety profiles, and cost-effectiveness.

While Fildena Professional is more commonly discussed in clinical settings or by patients seeking alternatives to branded medications, its presence in academic research projects grew as generics became more widely used due to their affordability and accessibility.